|1.||Pejler, Gunnar: 9 articles (09/2014 - 03/2009)|
|2.||Abrink, Magnus: 5 articles (09/2012 - 03/2009)|
|3.||Metz, Martin: 2 articles (02/2014 - 03/2013)|
|4.||Boato, Francesco: 2 articles (02/2014 - 03/2013)|
|5.||Nelissen, Sofie: 2 articles (02/2014 - 03/2013)|
|6.||Maurer, Marcus: 2 articles (02/2014 - 03/2013)|
|7.||Hendrix, Sven: 2 articles (02/2014 - 03/2013)|
|8.||Lemmens, Evi: 2 articles (02/2014 - 03/2013)|
|9.||Pehl, Debora: 2 articles (02/2014 - 03/2013)|
|10.||Daugas, Eric: 2 articles (08/2013 - 07/2010)|
09/15/2015 - "Kit(W-sh) mice reconstituted with MC deficient for mouse mast cell protease 4 did not restore normal mucosal healing or reduce efficiently inflammation after DSS withdrawal. "
11/15/2009 - "Moreover, the degree of lung tissue inflammation was markedly higher in mice lacking mMCP-4 than in WT controls. "
02/01/2014 - "Mast cells protect from post-traumatic spinal cord damage in mice by degrading inflammation-associated cytokines via mouse mast cell protease 4."
09/01/2013 - "Here we assessed the role of the chymase mouse mast cell protease 4 (mMCP-4) in allergic airway inflammation induced by house-dust mite (HDM) extract. "
07/01/2010 - "We conclude that mMCP-4 chymase, contrary to the global anti-inflammatory action of mast cells, aggravates GN by promoting kidney inflammation. "
01/01/2012 - "Our results show that with the exception of mMCP-4 expression of these mast cell chymase (mMCP-5), tryptases (mMCP-6 and 7), and carboxypeptidase A (mMC-CPA) increased during tumor progression. "
12/01/2000 - "Bone marrow-derived mast cells and the transplantable mast cell tumor MTC were shown to express the IgE receptor alpha-chain, MMCP-5 and CPA, as well as the mast cell tryptase MMCP-6 and the chymase MMCP-4, a protease expressed only during late stages of mast cell differentiation. "
08/01/2013 - "Mice deficient in mouse mast cell protease 4 (mMCP4), the functional counterpart of human chymase, had increased obstruction-induced fibrosis when compared to wild-type mice indicating a protective effect of mMCP4. "
10/01/2003 - "The gene expression of mMCP-4, -5 and -6 mRNA was increased at 5 days, and continued to increase to day 14, coinciding with a prominent inflammatory reaction and extensive myocardial necrosis and fibrosis. "
03/01/2009 - "Our findings identify a pathogenic role of mMCP-4 in autoimmune arthritis."
02/01/2010 - "Tranilast significantly reduced clinical and X-ray scores of arthritis and decreased numbers of TNF-alpha-positive mast cells and mRNA levels of TNF-alpha, chymase (mouse mast cell protease 4), tryptase (mouse mast cell protease 6), stem cell factor, interleukin-6, cathepsin-K, receptor activator of nuclear factor-kappaB, and of receptor activator of nuclear factor-kappaB-ligand, but increased interleukin-10 mRNA level in paws of arthritic mice. "
|3.||Carboxypeptidases A (Carboxypeptidase A)
|4.||Interleukin-6 (Interleukin 6)
|5.||Messenger RNA (mRNA)
|6.||Peptide Hydrolases (Proteases)
|8.||Receptor Activator of Nuclear Factor-kappa B (TRANCE-R)
|10.||Stem Cell Factor